Cellebrite
CLBT
116 hedge funds and large institutions have $749M invested in Cellebrite in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 18 reducing their positions, and 12 closing their positions.
2,726% more call options, than puts
Call options by funds: $650K | Put options by funds: $23K
183% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 12
172% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 18
75% more capital invested
Capital invested by funds: $427M → $749M (+$322M)
23% more funds holding
Funds holding: 94 → 116 (+22)
15.22% more ownership
Funds ownership: 28.61% → 43.84% (+15%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$20.5M |
| 2 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$11.6M |
| 3 |
Morgan Stanley
New York
|
+$9.92M |
| 4 |
VC
Voss Capital
Houston,
Texas
|
+$9.63M |
| 5 |
Two Sigma Investments
New York
|
+$7.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Makena Capital Management
Menlo Park,
California
|
-$24.1M |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$15.3M |
| 3 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$9.85M |
| 4 |
IP
Isomer Partners
New York
|
-$3.34M |
| 5 |
BCM
Brasada Capital Management
Houston,
Texas
|
-$2.76M |
CLBT Hedge Fund Activity: Q4 2023 in Review
116 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q4 2023, worth a combined $749M — up 75% from $427M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CLBT positions and 12 closed out — a net gain of 22 holders — while 49 added to existing stakes and 18 trimmed.
The largest buyer was Nine Ten Capital Management, adding an estimated $20.5M. The largest seller was Makena Capital Management, exiting entirely with an estimated $24.1M sold.
- 116 institutional investors held Cellebrite (CLBT) as of Q4 2023, up from 94 in Q3 2023.
- Funds reported $749M of Cellebrite stock for Q4 2023, up 75% quarter-over-quarter.
- 34 funds opened new Cellebrite positions in Q4 2023 and 12 closed out, a net change of +22 holders.
- The largest Cellebrite buyer in Q4 2023 was Nine Ten Capital Management, an estimated $20.5M added.
- The largest Cellebrite seller in Q4 2023 was Makena Capital Management, an estimated $24.1M sold.
Based on aggregated 13F filings for Q4 2023.